Stanford Interventional Radiology: A Cancer Survivors Story
We offer amazing new cancer treatments for our patients through our Interventional Radiology Program. Section Chief Lawrence Rusty Hofmann, MD, explains how our interventional radiologists use image guidance to target a cancerous tumor with great accuracy and employ cutting-edge therapies to kill the tumor without surgery through treatments such as radioembolization and chemoembolization. As a former patient describes, these revolutionary treatments are transforming lives.
Before coming to Stanford Hospital, Tony Ricciardi, whose lung cancer had expanded into his neck, was told he might have a year left to live. But doctors at Stanford gave Ricciardi hope, and four years after his diagnosis, he is cancer free.
Four-and-a-half months after being diagnosed with basal cell carcinoma, 101-year-old Winnie Bazurto's cancer was gone. Breakthrough target therapy treatment on skin cancer may do the same for other kinds of cancers, from pancreatic to colon to prostate.
Kipp Weiskopf and Aaron Ring were awarded top prize in the graduate student division of the Collegiate Inventors Competition for their idea of creating high-affinity SIRP-alpha molecules to block the CD47 "don't eat me" signal that keeps macrophage cells from consuming and destroying cancer cells. The molecule has the potential to vastly boost the power and killing potential of existing antibody therapies against a wide variety of cancers. Their advisors are Stanford professors Irv Weissman, MD, and Christopher Garcia, PhD.